Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023

Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023

60 $

Format : 18 MP4 + 2 PDFs

File Size : 13.52 GB

Category:

Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment 2023

Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment centers on the treatment of usual psychiatric patients with emphasis on the difficult to treat or treatment-resistant. Continuing medical education lectures will enhance your ability to choose treatments as you gain an understanding of the interface between psychiatric, neurological, and medical illness.

Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment is a comprehensive online course that delves into the treatment of psychiatric patients, with a particular focus on those who are difficult to treat or have treatment-resistant conditions. This course offers continuing medical education lectures that will enhance your ability to choose appropriate treatments and gain a deeper understanding of the interface between psychiatric, neurological, and medical illness.

Led by renowned faculty, this course covers a wide range of topics, including the latest advancements in antipsychotic medications and treatment augmentation. It also explores potential new uses for mood stabilizers and examines the neurobiological mechanisms of depression, with a focus on the role of inflammation. Furthermore, the importance of a therapeutic alliance when prescribing psychotropic medications is emphasized.

By participating in this online CME program, you will have the opportunity to explore current evidence-based and emerging treatments for various psychiatric conditions. Some of the topics covered include schizophrenia and bipolar disorder, bipolar and treatment-resistant depression, TMS and ECT, anxiety spectrum and sleep disorders, PTSD, alcohol and substance abuse disorders, women’s mental health issues, and child, adolescent, and geriatric psychopharmacology.

Learning Objectives

Upon completion of this course, you will be able to:

  • Describe lessons learned from genomic sequencing of patients with psychiatric illnesses
  • Identify unsolved problems regarding the pharmacologic treatment of schizophrenia and learn more effective treatments
  • Describe emerging theories and treatments of bipolar disorder, difficult-to-treat depression, bipolar depression, and anxiety disorder
  • Outline the perils and possibilities of psychedelics and ketamine
  • Recognize when to utilize ECT and TMS for treatment-resistant depression
  • Illustrate emerging treatments for PTSD
  • Review sleep disorders commonly comorbid with psychiatric illness and the appropriate use of medications and treatments
  • Review the interface of medicine and psychiatry with a focus on cancer and cardiovascular disease
  • Review the interface of neurology and psychiatry with an emphasis on functional neurological disease, hysteria, movement disorders, pain, OCD and others
  • Summarize the use of genetic tests, serum level measurements, and drug combinations in the treatment of resistant depression
  • Identify the current role of pharmacotherapy in the treatment of substance use disorders including alcohol, opioids, and cannabis
  • Review the role of pharmacotherapy in the treatment of psychiatric disorders throughout women’s reproductive lifespan, with a focus on the premenstrual, prenatal, postpartum, and perimenopausal periods
  • Examine the latest advances and problems associated with treatment approaches in the child, adolescent, and geriatric populations

Topics and Speakers

Lessons Learned from the DNA of Patients with Psychiatric Disorders – Daniel Weinberger, MD

Neurology and Psychiatry Interface – Martin Samuels, MD, DSc (hon)

The Interface of Medical and Psychiatric Disorders – Focus on Cancer and Heart Disease – Charles Nemeroff, MD, PhD

Tackling Unsolved Problems in the Pharmacological Treatment of Schizophrenia – Cognitive Impairment, Negative Symptoms, and Partial Treatment Response – Philip Harvey, PhD

Why You Should Order Living Legends in Psychopharmacology

This online course offers a unique learning experience that can greatly enhance your knowledge and skills in psychopharmacology. By participating in this course, you will have the opportunity to learn from renowned experts in the field and gain insights into the latest advancements in psychiatric treatments. Here are a few reasons why you should consider ordering this course:

1. Expert Faculty

The faculty for this course consists of living legends in the field of psychopharmacology. These experts have made significant contributions to the understanding and treatment of psychiatric disorders, and their expertise is invaluable for anyone looking to expand their knowledge in this area.

2. Comprehensive Coverage

This course covers a wide range of topics, ensuring that you will gain a well-rounded understanding of the field of psychopharmacology. From the treatment of schizophrenia and bipolar disorder to the use of psychedelics and ketamine as potential antidepressants, you will explore both established and emerging treatments for various psychiatric conditions.

3. Evidence-Based Approach

The treatments discussed in this course are based on the latest evidence and research findings. By learning about evidence-based treatments, you can make more informed decisions when it comes to prescribing medications and develop a better understanding of the underlying mechanisms of psychiatric disorders.

4. Continuing Medical Education

Participating in this course will earn you continuing medical education (CME) credits, allowing you to fulfill your professional development requirements while gaining valuable knowledge. These credits can contribute to your ongoing education and ensure that you stay up-to-date with the latest advancements in psychopharmacology.

5. Convenient Online Format

This course is delivered entirely online, making it convenient for busy healthcare professionals. You can access the lectures and course materials at your own pace and from the comfort of your own home or office. This flexibility allows you to fit your learning around your existing commitments.

Order Living Legends in Psychopharmacology Today

Don’t miss out on the opportunity to learn from the living legends in the field of psychopharmacology. Order Living Legends in Psychopharmacology: From Evidence Base to Advances in Treatment today and gain valuable insights into the treatment of psychiatric patients. With its expert faculty, comprehensive coverage, evidence-based approach, continuing medical education credits, and convenient online format, this course is the perfect resource for anyone looking to enhance their understanding of psychopharmacology.

Product Details

  • Schizophrenia and bipolar disorder
  • Bipolar and treatment-resistant depression
  • TMS and ECT
  • Anxiety spectrum and sleep disorders
  • PTSD
  • Alcohol and substance abuse disorders
  • Women’s mental health issues
  • Child, adolescent, and geriatric psychopharmacology
  • Describe lessons learned from genomic sequencing of patients with psychiatric illnesses
  • Identify unsolved problems regarding the pharmacologic treatment of schizophrenia and learning more effective treatments
  • Describe emerging theories and treatments of bipolar disorder, difficult-to-treat depression, bipolar depression, and anxiety disorder
  • Outline the perils and possibilities of psychedelics and ketamine
  • Recognize when to utilize ECT and TMS for treatment-resistant depression
  • Illustrate emerging treatments for PTSD
  • Review sleep disorders commonly comorbid with psychiatric illness, and appropriate use of medications and treatment
  • Review interface of medicine and psychiatry with a focus on cancer, cardiovascular disease
  • Review the interface of neurology and psychiatry with an emphasis on functional neurological disease, hysteria, movement disorders, pain, OCD and others
  • Summarize the use of genetic tests, serum level measurements, and drug combinations in treatment-resistant depression
  • Identify the current role of pharmacotherapy in the treatment of substance use disorders including alcohol, opioids, and cannabis
  • Review the role of pharmacotherapy in the treatment of psychiatric disorders throughout women’s reproductive lifespan, with a focus on the premenstrual, prenatal, postpartum, and perimenopausal periods
  • Examine the latest advances and problems associated with treatment approaches in the child, adolescent, and geriatric populations

Related Products